Skip to main content
Home
BE
  • nl
  • fr
  • en
  • Get to know Sciensano
    • About Sciensano
    • Sciensano in figures
    • Sciensano's structure
    • Contact Sciensano
    • Our commitment to quality, health, safety and environment
    • Our commitment to collecting and managing data
    • Partnerships
    • Emergency and Response
    • Working / doing an internship at Sciensano
    • Jobs
    • Values and standards
    • History of Sciensano
    • 2024 Annual report
    • Donations and bequests
  • Areas of expertise
    • List of health topics from A-Z
    • Health and disease monitoring
    • Animal Health
    • Effectiveness of safety of vaccines, medicines and health products - Quality of medical laboratories
    • Food consumption and food safety
    • Health and environment
    • Quality of healthcare
  • Our services
    • Analysis request
    • Data collection
    • External quality assessment
    • Control and Safety Assessment
    • Licensing
    • Health Information
    • Health Threats
    • Projects
    • Reports & Publications
  • Press Corner

Search form

/!\ Warning: site not updated

This website is a read only copy of our corporate website, as published on the 16th of September 2025, and will only be updated once a month.

This restriction is due to a number of attacks attempting to put our website down. Next update will occur on the 16th of October.

  1. Home
  2. People
  3. Stephane De Craeye

Primary tabs

  • View(active tab)
  • Publications

Dr. Stephane De Craeye PhD

Scientist

Works in:

Quality of laboratories

Publications

  • Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
  • Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial
  • Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial (poster)
  • Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes.
  • Pork as a source of transmission of Toxoplasma gondii to humans: a parasite burden study in pig tissues after infection with different strains of Toxoplasma gondii as a function of time and different parasite stages.
Read more

Contact form

Please note that your message will require a validation before being sent to the person. You will receive an email at your address, containing a link for validating your message.

QR code

QR code for this page URL

Sciensano info

 +32 2 642 51 11
 info@sciensano.be
 contact
 +32 2 642 50 01

Postal address

Sciensano
Rue Juliette Wytsmanstraat 14
1050 Brussels, Belgium

About us
Sciensano jobs
Responsibility and privacy
Privacy notice
Accessibility statement
Privacy Settings

Sciensano Logo